LENZ Therapeutics Inc
Research LENZ Therapeutics Inc (LENZ) on Bullrun: market cap USD 180.60M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLENZ
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 180.60M
- Financial periodFY2025
- RevenueUSD 19.09M
- Net income-USD 82.13M
- Free cash flow-USD 70.00M
- Gross margin97.8%
Valuation Snapshot
latest market cap is USD 180.60M.
About LENZ Therapeutics Inc
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Frequently asked questions
What is LENZ Therapeutics Inc's market cap?
LENZ Therapeutics Inc's market capitalization is USD 180.60M.
What does LENZ Therapeutics Inc do?
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc.